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Abstract
Esophageal carcinoma is the ninth most common cancer in the world, which is frequently 
seen in Asia and east Africa. Around 80% of all cases occurred in less-developed regions. 
Two major histological subtypes of esophageal carcinoma, adenocarcinoma and squa-
mous cell carcinoma, are known to differ greatly in terms of risk factor, epidemiology, 
male to female ratios, and incidence. Lymph node metastasis is a crucial factor in staging 
and prognosis is associated with surgical treatment and a major lymphatic chain into 
the neck. Esophageal adenocarcinoma (EAC) is mainly detected at the lower third of the 
thoracic esophagus or esophago-gastric-junction (EGJ) and metastasizes mainly to lymph 
nodes of the lesser sac, celiac regions and lower mediastinal. Esophageal squamous cell 
carcinoma (ESCC) has a predilection for metastasis to the lymph nodes of the cervical 
region including recurrent laryngeal nerve (RLN) on both sides. Lymph node dissection 
is vital yet difficult, left-side lymph node dissection especially requires expertise. There 
are some reports on lymph node dissection in the prone position by video-assisted thora-
coscopic surgery of the esophagus (VATS-E) along the left RLN in Japan and China. We 
also introduce a stripping method for lymph node dissection in this site.
Keywords: recurrent laryngeal nerve, lymph node dissection, video-assisted 
thoracoscopic surgery (VATS-E)
1. Introduction
Esophageal carcinoma is strongly invasive and is accompanied by numerous malignant 
tumors. It is mainly seen in Asia and East Africa. In the eastern countries, especially in Japan, 
extended lymph node dissection, including the abdominal, upper, middle, lower mediastinal, 
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and occasionally cervical lymph nodes, is suggested as a standard surgical method because 
systematic dissection of metastatic lymph nodes is thought to improve survival and lead 
to cure.
Consequently, recommending complete lymphadenectomy of the upper mediastinum is 
an essential component in radical esophagectomy for esophageal squamous cell carcinoma 
(ESCC). Three-field lymphadenectomy (3FL) is the ultimate surgical procedure in the pursuit 
of complete lymph node dissection for thoracic esophageal cancer. However, lymph node 
dissection along the recurrent laryngeal nerve (RLN) is difficult because severance of nerves 
by electrical devices can easily lead to paralysis [1, 2].
The prone position provides better visualization in the subaortic arch and subcarinal and 
supraphrenic regions, but the working space in the left upper mediastinum for dissecting 
the lymph nodes along the left recurrent laryngeal nerve is limited. Some investigators, 
including us, have shown how to obtain a good operative field in the upper mediastinum 
for lymph adenectomy. Osugi reported that tracheobronchus must be retracted ventrally 
to visualize the left side of the trachea and developed the retractor that provides exposure 
of the entire mediastinum and esophagus in left lateral position [3]. In eastern countries, 
surgeons also describe lymphadenectomy along the left recurrent laryngeal nerve, but few 
surgeons in western countries have discussed lymphadenectomy of esophageal adenocar-
cinoma (EAC). Here, we describe differences in lymph node metastasis between ESCC and 
EAC and procedures for lymph node dissection along the recurrent laryngeal nerve in ESCC.
2. Etiological differences between esophageal squamous cell carcinoma 
(ESCC) and esophageal adenocarcinoma (EAC)
Esophageal carcinoma is seen in two major histological subtypes: adenocarcinoma and squa-
mous cell carcinoma (SCC). These subtypes are very different in terms of risk factors and epi-
demiology. According to GLOBOCAN 2012, there were an estimated 400,000 cases of ESCC 
and 50,000 cases of EAC of the esophagus in 2012 worldwide [4].
2.1. Global incidence of ESCC
In 2012, the global incidence of ESCC was 5.2 per 100,000 people. Most affected regions were 
located in Eastern and South-East Asia, followed by sub-Saharan Africa and Central Asia [4]. 
About 80% of global ESCC cases occur in Central and South-East Asian regions. China alone 
provided more than 50% of the global cases. Areas of high incidence of ESCC have been iden-
tified in Northern Iran, Central Asia, and China (together forming the so-called ”esophageal 
cancer belt”) as well as parts of Eastern Africa. ESCC is more common and the rate of ESCC 
is about 95% in Japan [3].
2.2. Risk factor of ESCC
Generally, chronic inflammation of the esophageal mucosa is postulated to increase the risk of 
ESCC. Two major risk factors are smoking and alcohol consumption, which have been found 
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to account for more than 75% of all SCC cases in high-income countries [5]. On the other hand, 
frequent consumption of extremely hot beverages is a common risk factor for ESCC in less-
developed regions [4]. Consumption of hot mate drinks in Latin America and hot beverages 
in Southern China are associated with the risk of ESCC [4, 5].
In Iran, opium use has been found to increase mortality from esophageal cancer by 50%. 
High-incidence areas in Africa suggest that smoking, occupational exposures and nutritional 
deficiencies may be responsible for the high burden of ESCC [4].
Alcohol drinking is a well-established risk factor for esophageal cancer. International Agency 
for Research on Cancer (IARC) referred to acetaldehyde, an oxidative metabolite of ethanol, as 
a potential causative agent behind alcohol-induced carcinogenesis based on evidence of inter-
action between alcohol consumption and acetaldehyde dehydrogenase (ALDH2) enzyme gene 
polymorphisms [6, 7]. Oze et al. showed that acetaldehyde dehydrogenase Glu504Lys polymor-
phism had strong effect modification with alcohol drinking and concluded that there is con-
vincing evidence that alcohol drinking increases the risk of esophageal cancer in the Japanese 
population [8]. Half of the Japanese population is heterozygous or homozygous for the *2 allele 
of ALDH2, showing respectively, peak blood acetaldehyde concentrations in post-alcohol 
consumption 6- and 19-fold higher than homozygous wide-type individuals [9]. As a result, 
ALDH2*2/*2 homozygous carriers show facial flushing and nausea after alcohol consumption 
that deters them from drinking, whereas heterozygotes exhibit less severe reactions [9]. Fang et 
al. indicated that individuals heterozygous for the *2 variant allele of aldehyde dehydrogenase 
2 (ALDH2*1/*2) frequently detected in Asia had an increased risk of esophageal cancer, espe-
cially among heavy drinkers, because inactive ALDH2 fails to metabolize acetaldehyde rapidly, 
leading to excessive accumulation of acetaldehyde in blood and repeated high exposure to acet-
aldehyde after drinking. Drinking clearly modifies the effect of ALDH2 on esophageal cancer 
risk in Asians [6].
2.3. Global incidence of EAC
The global incidence of EAC is 0.7 per 100,000 people. Highest incidence rates by region were 
found in Northern and Western Europe, North America, and Oceania [4]. On the national 
level, the highest rates were seen in the UK, the Netherlands, Ireland, Iceland, and New 
Zealand. The burden of AC is the highest in Northern and Western Europe, North America, 
and Oceania, accounting for 46% of all global AC cases [4, 10, 11].
2.4. Risk factor of EAC
The strongest known risk factor for EAC is gastroesophageal reflux disease and its more 
severe manifestation, Barrett’s esophagus (BE). Obesity promotes the development of gastro-
esophageal reflux and also acts as an independent risk factor for EAC.
In North America and Northern and Western Europe, prevalence of Helicobacter pylori (H pylori) 
infection is among the lowest and incidence of EAC is higher [4, 10, 11].
Helicobacter pylori (H pylori) lowers gastric acid secretion and decreases gastric esophageal 
reflux [10, 11]. In more recent years, prevalence of the latter has leveled out in high-prevalence 
countries such as the Netherlands and the UK [4].
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3. Clinical difference between EAC and ESCC
3.1. Location of ESCC and EAC
In 50–60% of cases, ESCC is located in the middle third thoracic esophagus in Thailand, Iran, 
and Japan [3, 12, 13, 14]. About 60% of SCCs is also located in the middle third of the esopha-
gus in Iran. Several studies have found that ESCC was most commonly located in the lower 
third of the esophagus, such as studies conducted in Ghana [15].
In 80% of cases, EAC is located at the gastroesophageal junction (GEJ) and 20% in the lower 
third thoracic esophagus. This entity is capable of producing EAC directly or, more com-
monly, through an intermediate pre-neoplastic lesion or Barrett’s esophagus (BE). BE is a 
pre-malignant lesion that develops in 6–14% of patients with Gastroesohageal reflux disease 
(GERD), of which approximately 0.5–1% will develop EAC [10, 11]. Increased incidence 
of BE in the past 30 years correlates with an increased incidence of EAC during the same 
period.
4. Clinical difference of lymph node metastasis between ESCC and EAC
4.1. Lymph node metastasis of ESCC
Udagawa et al. showed that it was necessary to dissect the cervical lymph nodes, particularly 
for tumors located in the upper and middle thoracic esophagus [2]. Bilateral cervical para-
esophageal node dissection is predominantly effective and the inclusion of these stations in 
the regional lymph nodes is justified in the 7th TNM classification. The lower jugular or 
supraclavicular region lymph nodes are also important. Abdominal lymph node dissection 
is also effective, but the effectiveness is limited in upper esophageal cancer. The statistical 
efficacy index (EI) of individual lymph node stations according to the main tumor location, a 
more precise modification of the range of lymph node dissection is possible. Although medi-
astinal nodes are important in general, not all are located in the esophageal drainage area. 
Some specific stations such as pretracheal, left tracheobronchial, and supradiaphragmatic 
show least efficacy by dissection. The mediastinal node stations can be re-arranged such as 
recurrent laryngeal, paraesophageal, posterior mediastinal, subcarinal, and subbronchial in 
order, according to EI. The number of metastatic lymph nodes may be a better prognostic fac-
tor than Japanese N grading. The Japanese N-grouping seems to be more efficient for predict-
ing of the radical and safe operation. It is difficult to detect lymph node metastasis clinically. 
Japanese N-grouping may be also more available in stage assessment because a single obvi-
ous distant lymph node metastasis in Japanese N-group can correctly identify a higher stag-
ing. Japanese Surgeons are afraid that discussion about lymph node dissection with  precision 
is no longer possible if meticulous node grouping based on detailed data of lymph node 
stations is once discontinued.
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Ma et al. stated that 3FL improves overall survival rate but has more complications. 
Because of the high heterogeneity among outcomes, definite conclusions are difficult to 
draw [16].
4.2. Lymph node metastasis of EAC
Sepesi et al. reported 72% of patients presented with clinically involved lymph nodes showed 
metastasis in the lesser sac (perigastric/perihepatic) [17]. However, 11% of patients had meta-
static lymph nodes located at the celiac artery, and 10% had nodal disease in the paratracheal 
region. Ninety-eight patients demonstrated clinical metastatic involvement in one or two nodal 
basins (example: perigastric and paratracheal); only about 2% of patients presented nodal dis-
ease in three nodal basins. Feith et al. reported the prevalence and number of lymph node metas-
tases according to pT category in patients with primary resected Barrett’s carcinoma. A strong 
correlation between the pT category and the presence and the number of lymph node metasta-
ses was detected [18]. Lymph node metastases in more than 95%of the patients was detected in 
the lower posterior mediastinum, in the bilateral paracardiac region, or in the region of lesser 
curvature and left gastric artery of the abdomen. Prevalence of lymph node metastases at the 
various topographic locations in relation to the T category of the underlying Barrett’s carcinoma 
is shown. As T category increases, prevalence of regional lymph node metastases also mark-
edly increases. Lymph node metastases to more distant locations, such as the tracheal bifurca-
tion region, the proximal mediastinum, or celiac axis, lagged behind and were common only in 
patients with more advanced primary tumors. This suggests that lymphatic spread occurs in 
an orderly fashion. Patients who had many lymph nodes metastasis had distant lymph node 
metastasis in the upper mediastinum and tracheal bifurcation area that can be reached by a 
transthoracic approach [19]. According to an increasing number of lymph nodes metastasis, 
positive lymph node metastasis in the upper mediastinum and carinal region also increased. 
Prevalence of lymph node metastases at the celiac axis was also detected with increasing num-
ber of lymph nodes metastasis. There was significantly frequent lymph nodes metastasis in 
the upper mediastinal, carinal or celiac regions among patients with more than three positive 
regional nodes. Overall, skipping of regional lymph node stations, positive distant nodes in the 
absence of positive regional nodes, was seen in less than 5% of the patients.
Yamashita et al. reported clinical records of 2807 EGJ carcinoma patients without preopera-
tive therapy in Japan [20]. There are obvious unbalances in terms of lymph node dissection 
rate according to histology and the main tumor location. Lymph nodes metastasis frequently 
involved abdominal lymph nodes. Lymph nodes at the right and left cardia, lesser curvature 
and along the left gastric artery were especially metastasized. Lymph nodes along the greater 
curvature of the stomach were not frequently metastatic, and advantage of dissection seemed 
unlikely. Lower mediastinal node dissection may contribute to improved survival for patients 
with esophagus-predominant EGJ carcinoma. However, due to low dissection rates for nodes 
of the middle and upper mediastinum, no conclusive results have been obtained regarding 
the optimal extent of nodal dissection in this region.
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5. Lymph node metastasis along the recurrent laryngeal nerve
Extensive lymphadenectomy with esophagectomy for esophageal carcinoma improves the 
prognosis in Japan. In particular, lymph nodes along the RLN are considered as significantly 
important lymph nodes those are recommended to be completely dissected. However, lymph 
node along the RLN dissection complicates high morbidity and mortality. Udagawa et al. 
showed lymph node metastasis along the rt. RLN and cervical paraesophageal at a rate of 
31.9, 22.2%, 19, 13.9%, and 14.7, 12.4% of upper, middle, and lower thoracic esophagus, respec-
tively. Lymph node metastasis along the lt. RLN and cervical paraesophageal was found at 
a rate of 19.1, 20.1%, 14.1, 8.3%, and 8.1, 5% of upper, middle, and lower thoracic esophagus 
in Japan, respectively [2]. Ye et al. reported that the recurrent laryngeal nerve lymph node 
metastasis from esophageal carcinoma is detected at the rate of 34.2% in China [21]. Lymph 
node metastasis along the recurrent laryngeal nerve was detected, and the rate of lymph 
node metastasis was 23.4%. The rate of rt. RLN lymph node metastasis was 20.8%, which 
was slightly higher than the rate of lt. RLN lymph node metastasis which had a rate of 15.8%.
5.1. ESCC
In ESCC, lymph node metastasis is possible to occur in the neck, mediastinum, and abdomen. 
The location of RLN lymph node is from the upper mediastinum and to the cervical region, 
where lymph node metastasis is frequently detected in thoracic ESCC. Early, initial and micro 
metastasis of ESCC often occur and RLN lymph node metastasis has been regarded as an 
indication for three-field lymphadenectomy in the surgical treatment of ESCC. More impor-
tantly, RLN metastasis has been shown to be a strong predictor of poor prognosis in ESCC.
There are many reports about lymph node metastasis along the recurrent laryngeal nerve in 
Asia. In Japan, Igaki et al. reported that cervical or celiac lymph node metastasis in patients 
with carcinomas of the lower thoracic esophagus should be distinguished from pathologic M1 
status in the UICC-TNM staging system [1].
5.2. EAC
Giacopuzzi et al. reported that in Siewert type I tumors, when standard mediastinal lymph-
adenectomy is performed, about half of the node-positive patients show positive nodes in 
mediastinal stations [22]. Specifically, upper and mid mediastinal lymph node metastases 
(right paratracheal, subcarinal, aortopulmonary window) were reported in up to 25% of 
patients. When the few studies in which cervical nodes are also removed are considered, a 
non-negligible incidence of metastases is detectable, but, due to the scarcity of available data 
and the higher complication rate of three-field dissection, this is not currently thought to be 
relevant in clinical practice. Mediastinal nodes are involved in about 30% of Siewert type 
II cases. Although most of the positive nodes occur at lower stations, the rate of metastasis 
detected in the upper-mid mediastinum after transthoracic esophagectomy ranges between 
8 and 22% [22].
Esophageal Abnormalities78
6. Lymph node dissection along the recurrent laryngeal nerve
6.1. ESCC
Surgeons in Asia, where the rate of ESCC is higher, perform lymphadenectomy along the 
recurrent laryngeal nerve. Udagawa et al. reported that cervical lymph node dissection 
had high efficacy index (EI) in upper and middle thoracic esophageal cancer but a low 
EI in lower esophageal cancer. Cervical lymphadenectomy for lower esophageal cancer 
showed some but limited efficacy only in cervical paraesophageal stations [2]. Three-field 
lymph node dissection may be indicated even for patients with clinical Stage I ESCC requir-
ing surgical intervention because this surgical procedure offers possible cure by removing 
unsuspected lymph node metastasis. Altorki et al. also mentioned that three-field lymph 
node dissection with esophagectomy can involve with a low mortality and reasonable mor-
bidity. Unsuspected metastases to the lymph nodes along the RLN and cervical region 
are present in 36% of patients in spite of histological tumor type or tumor location of the 
esophagus [23].
Osugi et al. reported that video-assisted thoracoscopic surgery (VATS), a less invasive method 
that preserves curability, provides comparable results to open radical esophagectomy. 
Palanivelu et al. demonstrated the lymph node dissection along the recurrent laryngeal nerve 
in prone position to be effective [24].
6.2. EAC
Lagergren et al. indicated that the extent of lymphadenectomy during surgery for esopha-
geal carcinomas which include 83.5% adenocarcinoma may not influence 5-year all-cause or 
disease-specific survival [25]. These results challenge current clinical guidelines.
Feith et al. showed that a transthoracic approach followed by an extended lymph node dis-
section in the upper mediastinum is not recommended in patients with adenocarcinoma of 
the distal esophagus. Conservative surgical resection due to the virtual absence of lymph 
node metastasis in the upper mediastinum can cure patients with high-grade dysplasia and 
pT1a carcinoma. In addition systematic lymph node dissection of the lower posterior medi-
astinum and upper abdominal compartment can improve the prognosis in patients with 
more advanced tumors and a limited number of regional lymph node metastases. A trans-
mediastinal approach with a wide splitting of the esophageal hiatus can achieve this radical 
lymph node dissection in the lower posterior mediastinum and upper abdominal compart-
ment. Multimodal treatment protocols including chemotherapy and irradiation on systemic 
therapy are considered to be more appropriate for patients with more extensive lymph node 
metastases [25].
Cuscheri et al. recommended placing the patient prone to clear the posterior mediastinum, 
thus avoiding lung compression, but did not demonstrate lymph node dissection along the 
recurrent laryngeal nerve in EAC patients [26].
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6.3. Lymph node dissection along the rt. recurrent laryngeal nerve
Thoracoscopic lymph node dissection along the right (rt.) recurrent laryngeal nerve has 
been more readily demonstrated by various authors. The rt. recurrent laryngeal nerve LN 
is removed as follows: the location of the right vagal nerve and the right inferior subclavian 
artery are confirmed. The airway behind the mediastinal pleura is opened to expose the right 
subclavian artery. The rt. recurrent laryngeal nerve is separated from the right vagal nerve 
followed by blunt dissection of the right recurrent laryngeal nerve through the vagus nerve 
trunk at the level of the right subclavian artery. We performed VATS-E in prone position 
(Figure 1). The surrounding LNs and fatty tissues are subsequently removed from the right 
recurrent laryngeal nerve [27] (Figure 2).
To reduce the risk of paralysis, an electric device is used to separate the nodes from the recur-
rent laryngeal nerve within 2 s [27].
6.4. Lymph node dissection along the lt. recurrent laryngeal nerve
Lymph nodes along RLNs are thought to be significantly involved by carcinoma cells as 
well as a main lymphatic chain to the neck, and complete dissection of these nodes is rec-
ommended. However, a lymphadenectomy, especially along the left RLN by thoracoscopic 
esophagectomy, is considered to be a burdensome step due to difficult operative exploration 
at the left upper mediastinum. To achieve a precise dissection of this portion, stable operative 
views and technical feasibility are necessary. Noshiro et al. mentioned that in their lymphad-
enectomy procedure along the left RLN, performing a thoracoscopic esophagectomy in the 
prone position had advantages compared to surgery in the left lateral decubitus position [27]. 
They introduced such details, during the procedure, the trachea is rolled back carefully and 
firmly to the right and ventrally by a grasper holding small gauze to explore the left aspect 
of the trachea and the left bronchus. The tissue, including the left RLN and lymph nodes, is 
Figure 1. Port site in prone position. 3rd ICS, middle A.L.(1), 5th ICS, posterior A.L.(2), 7th ICS, posterior A.L.(3), 9th ICS, 
SSCL(4), 7th ICS, SSCL(5). ICS: inter costal space, AL: axillary line, SSCL: subscapular line.
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dissected sharply just along the trachea and the left bronchus to make a ventral border of 
dissection. Finally, the left RLN is sharply isolated from the explored tissue without using an 
electric device to avoid injury by electricity or heat, and the lymph nodes were consequently 
dissected in an en-bloc fashion accompanied with the divided thoracic duct.
However, dissecting the lymph nodes along the left RLN during VATS is challenging and 
requires significant technical skill, and there is limited working space in the left upper medi-
astinum for dissecting the lymph nodes along the left RLN and expertise in dissection is 
required. The technique of lymph node dissection along the lt. RLN in VATS-E has been dem-
onstrated by some authors (Table 1).
We have previously reported a “Stripping method” to overcome this disadvantage in prone 
position [28]. Therefore, we considered stripping the esophagus toward the neck to remove 
the esophagus. Both the esophagus and stomach tube in the upper mediastinum are cut apart 
from the tumor by a linear stapler after isolating the esophagus (Figure 3A). The residual 
esophagus is stripped in the reverse direction and retracted toward the neck when the stomach 
Method Position
Stripping method Makino et al. [28, 29] Prone position
Bascule method Oshikiri et al. [30] Prone position
Suspension method Xi et al. [31] Prone position
Suspension method Zheng et al. [32] Prone position
LN dissection of hybrid position Kaburagi et al. [33] Hybrid position
Looping method Lin et al. [34] Prone position
Mediastinoscopic LN dissection Fujiwara et al. [35] Spine position
Table 1. Methods of lymph node dissection along the RLN.
Figure 2. Lymph node dissection along the rt. RLN.
Lymph Node Dissection along the Recurrent Laryngeal Nerve in Video-Assisted Thoracoscopic...
http://dx.doi.org/10.5772/intechopen.69524
81
tube is removed through the nose by anesthesiologist (Figure 3B). The wide operative field 
of left upper mediastinum is possible using this stripping technique. Lymph node dissection 
is performed after stripping the residual esophagus [28, 29] (Figure 4A). Moreover, working 
space is created by compressing the right main bronchus or retracting the trachea using a 
retractor. Lymph node and fat tissue are ablated from the left edge of the trachea, after which 
lymph node along the left RLN is dissected (Figure 4B). An electrical device is used to separate 
the node from the nerve, and endoscopic scissors and forceps are used during sharp dissection 
along the nerve. One hundred patients with esophageal carcinomas underwent VATS-E (27 
in left lateral position and 73 in prone position). This original technique of lymphadenectomy 
along the left RLN has been performed in 54 patients in the prone position VATS-E. The rate 
of transient recurrent laryngeal nerve palsy is 17.2%, but permanent palsy is only 1.2% [29].
Oshikiri et al. developed the “Bascule method” where the proximal portion of the divided 
esophagus and tissue that includes the left RLN and lymph nodes are drawn through a gap 
between the vertebral body and the right scapula [30]. The membranous portion between the 
esophagus and the trachea like the esophageal mesenteriolum is ablated by traction of the tis-
sue including the left RLN and lymph nodes along the left RLN by the proximal esophagus. 
The lymph node along the left RLN is distinguished from the left RLN and the tracheoesopha-
geal artery on the posterior side of the left RLN can be detected and easily cut by this traction 
A B
Lt.RLN
Lt.RLN
LN
trachea
Figure 4. (A) Lymph node dissection along the lt. RLN. (B) After LN dissection along the lt. RLN.
A B
esophagus
Stomach tube
esophagus
Figure 3. (A) Cutting both the esophagus and stomach tube. (B) Stripping by pulling the stomach tube.
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technique. The esophageal mesenteriolum is possibly drawn by taping of the entire length of 
the undivided esophagus. However, there is a limit to the amount of retraction. Division of 
the esophagus increases the amount of retraction possible, allowing for further drawing and 
development of the operative field.
Xi et al. and Zheng et al. showed an esophageal suspension method in scavenging peripheral 
lymph nodes of the lt. RLN. In this method, a traction line is used to suspend the incompletely 
stripped esophagus [31, 32]. Tissues including the left RLN and lymph nodes were extended, 
which improved operative exposure. Tissue is released in the area close to the trachea and 
left main bronchus in order to dissect the ventral and cranial borders. The left RLN and LNs 
are easily recognizable. The lt. RLN to the thyroid gland and the lymph nodes along the left 
RLN are separated using endoscopic scissors, keeping the remaining lymph nodes attached 
to the esophagus.
Kaburagi et al. demonstrated hybrid position method that radical lymphadenectomy along 
the bilateral recurrent laryngeal nerves was performed in the left lateral decubitus position 
because this approach was superior for lymphadenectomy in the region. Thoracoscopic 
esophagectomy and other lymphadenectomy were provided in the middle to lower medias-
tinum in prone position [33].
Lin et al. reported that after looping the esophagus and fixation with a clip, the exposed tho-
rax part of the thread is pulled up by the assistant to lift esophagus [34]. The left RLN is then 
exposed and separated in the space between lifted esophagus and the trachea. Scissor and isolat-
ing forceps are preferred during separation due to safety concerns. During subsequent mobili-
zation of the esophagus and dissection of left RLN lymph nodes, the assistant uses the grasping 
forceps to compress the trachea so as to better expose the space between esophagus and trachea.
Fujiwara et al. reported that the lymph nodes along the left RLN could be separated from the 
left RLN trunk using endoscopic scissors under a mediastinoscope, with the nodes remaining 
attached to the esophagus [35]. First, the nerve trunk is exposed along the anterior plane, then, 
the lymph nodes are retracted to the left, through beneath the nerve trunk, and separated by 
dividing the attachment to the nerve trunk. Finally, the subaortic arch lymph nodes are dis-
sected by dividing the attachment to the nerve trunk.
To avoid injury to the lt. RLN by electricity or heat, an electric device should not be used. 
Wong et al. demonstrated that a more aggressive and thorough nodal dissection may be pos-
sible with less concern of RLN injury by the availability of intermittent nerve mapping and 
continuous intraoperative nerve monitoring (CIONM) [36].
7. Conclusion
In eastern countries ESCC is common and lymph node metastasis along the RLN is frequently 
seen. Many surgeons in Japan, China and India perform thoracoscopic lymph node dissection 
along the RLN. The prone position allows for visualization of a dry and wide surgical space 
without the need for special assistants, but there is difficulty in lymph node dissection along 
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the left RLN. To obtain a good and wide operating field for lymph node dissection along the 
left RLN, only retraction or rotation of the trachea toward the right is insufficient. With our 
technique, the residual esophagus can easily be pulled up to the neck after sufficient ablation. 
In this technique, it is not necessary to retract the esophagus with more holes or to fix the 
esophagus. Esophageal stripping in lymph node dissection is easier and more effective than 
other methods.
Lymph node dissection along the left RLN after esophageal stripping is possible in the prone 
position during VATS-E.
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